MedLumics, a cardiac device company specializing in optically guided minimally invasive instruments, announced today that it has raised... Read more

Seroba’s investee company, PQ Bypass, today announced CE (Conformité Européenne) Mark approval for a trio of proprietary devices: T... Read more

 

Prexton Therapeutics Series B financing round raises €29 million ($31M) to advance its novel Parkinson’s therapeutic.... Read more

Seroba’s investee company, Quanta Dialysis Technologies Ltd (“Quanta” or the “Company”), a medical device company providi... Read more

TOP